These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36585388)

  • 1. microRNAs-based diagnostic and therapeutic applications in liver fibrosis.
    Zhao X; Xue X; Cui Z; Kwame Amevor F; Wan Y; Fu K; Wang C; Peng C; Li Y
    Wiley Interdiscip Rev RNA; 2023; 14(4):e1773. PubMed ID: 36585388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of miRNAs in liver diseases: Potential therapeutic and clinical applications.
    Doghish AS; Elballal MS; Elazazy O; Elesawy AE; Elrebehy MA; Shahin RK; Midan HM; Sallam AM
    Pathol Res Pract; 2023 Mar; 243():154375. PubMed ID: 36801506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases.
    Wang X; He Y; Mackowiak B; Gao B
    Gut; 2021 Apr; 70(4):784-795. PubMed ID: 33127832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation.
    Messner CJ; Schmidt S; Özkul D; Gaiser C; Terracciano L; Krähenbühl S; Suter-Dick L
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs: Small molecules with big impacts in liver injury.
    Abdel Halim AS; Rudayni HA; Chaudhary AA; Ali MAM
    J Cell Physiol; 2023 Jan; 238(1):32-69. PubMed ID: 36317692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
    Matsuda M; Seki E
    Semin Liver Dis; 2020 Aug; 40(3):307-320. PubMed ID: 32242330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs in Hepatic Stellate Cells and Hepatic Fibrosis: An Update.
    Zhu S; Chen X; Chen Y; Li XF; Chen SY; Li JJ; Wang A; Huang C; Li J
    Curr Pharm Des; 2021; 27(27):3000-3011. PubMed ID: 33100194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis.
    Roy S; Benz F; Vargas Cardenas D; Vucur M; Gautheron J; Schneider A; Hellerbrand C; Pottier N; Alder J; Tacke F; Trautwein C; Roderburg C; Luedde T
    J Dig Dis; 2015 Sep; 16(9):513-24. PubMed ID: 26120970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families.
    Murakami Y; Toyoda H; Tanaka M; Kuroda M; Harada Y; Matsuda F; Tajima A; Kosaka N; Ochiya T; Shimotohno K
    PLoS One; 2011 Jan; 6(1):e16081. PubMed ID: 21283674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.
    Greene CM; Varley RB; Lawless MW
    World J Gastroenterol; 2013 Aug; 19(32):5212-26. PubMed ID: 23983424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA: role in macrophage polarization and the pathogenesis of the liver fibrosis.
    Yu W; Wang S; Wang Y; Chen H; Nie H; Liu L; Zou X; Gong Q; Zheng B
    Front Immunol; 2023; 14():1147710. PubMed ID: 37138859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra- and Intra-Cellular Mechanisms of Hepatic Stellate Cell Activation.
    Yan Y; Zeng J; Xing L; Li C
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis.
    Su Q; Kumar V; Sud N; Mahato RI
    Adv Drug Deliv Rev; 2018 Apr; 129():54-63. PubMed ID: 29391222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma.
    Baglieri J; Brenner DA; Kisseleva T
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis.
    Teng KY; Ghoshal K
    Gene Expr; 2015; 16(4):155-62. PubMed ID: 26637395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection.
    Lee CH; Kim JH; Lee SW
    Curr Drug Targets; 2017; 18(7):756-765. PubMed ID: 27033188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signaling.
    Hyun J; Jung Y
    World J Gastroenterol; 2016 Aug; 22(29):6652-62. PubMed ID: 27547008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma.
    Li H
    Dig Liver Dis; 2022 May; 54(5):598-613. PubMed ID: 34344577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.